Related Experiment Video
Updated: Sep 29, 2025
07:39
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.6K
Endocannabinoid signaling in glioma
Carlos Costas-Insua1,2,3, Manuel Guzmán1,2,3
1Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Glia
|March 24, 2022
Summary
Cannabinoids show anti-tumoral effects against high-grade gliomas by targeting cancer cells and the tumor microenvironment. Further research into the endocannabinoid system could improve cannabinoid-based brain cancer therapies.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Pharmacology
Background:
- High-grade gliomas are aggressive primary brain tumors in adults.
- Glioma cells express cannabinoid receptors (CB1 and CB2) and endocannabinoid system components.
Purpose of the Study:
- To explore the anti-tumoral effects of cannabinoid receptor activation in glioma.
- To understand the role of the endocannabinoid system in glioma progression and treatment.
Main Methods:
- Preclinical studies investigating cannabinoid receptor modulation in experimental glioma models.
- Analysis of intracellular signaling pathways affected by cannabinoid treatment.
Main Results:
- Pharmacological activation of cannabinoid receptors demonstrates significant anti-tumoral effects in glioma models.
- Observed inhibition of cancer cell survival, proliferation, invasiveness, angiogenesis, and stem-like properties.
Conclusions:
- The endocannabinoid system plays a complex, context-dependent role in glioma.
- Optimizing cannabinoid-based therapies requires a deeper understanding of these mechanisms for clinical application.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
379
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
379
01:19Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K